| |
| |
|
| Insider
Information: |
Sandell Scott D |
| Relationship: |
10% Owner |
| City: |
Baltimore |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
84 |
|
| Direct
Shares |
187,325,142 |
|
|
Indirect Shares
|
366,464,633 |
|
|
| Direct
Value |
$933,719,656 |
|
|
|
Indirect Value
|
$1,395,703,557 |
|
|
| Total
Shares |
553,789,775 |
|
|
| Total
Value |
$2,329,423,212 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
48
|
|
Stock
price went up :
|
3
|
29
|
| Stock
price went down : |
3
|
19
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
 19.1%
|
1,485.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Welltek Incorporated |
WTKND |
Former 10% Owner |
|
0 |
2004-09-28 |
14,470 |
Premium* |
|
|
Aradigm Corp |
ARDM |
10% Owner |
2003-12-11 |
0 |
2003-12-17 |
0 |
Premium* |
|
|
Gyre Therapeutics |
GYRE |
10% Owner |
2006-04-12 |
0 |
2013-12-05 |
4,563,512 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
2,083,426 |
Premium* |
|
|
Vonage Holdings Corp |
VG |
10% Owner |
2006-05-30 |
0 |
2011-03-11 |
22,793 |
Premium* |
|
|
Innerworkings Inc |
INWK |
10% Owner |
|
0 |
2012-03-28 |
15,000 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
2011-03-10 |
0 |
|
0 |
Premium* |
|
|
Echo Global Logistics Inc |
ECHO |
10% Owner |
|
0 |
2012-02-28 |
901 |
Premium* |
|
|
Motricity Inc |
MOTR |
10% Owner |
2010-06-23 |
3,122,460 |
2010-06-23 |
0 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2010-06-30 |
33,819,441 |
2014-08-29 |
4,659,333 |
Premium* |
|
|
Glu Mobile Inc |
GLUU |
10% Owner |
2011-08-08 |
5,919,443 |
2010-08-27 |
0 |
Premium* |
|
|
Boingo Wireless Inc |
WIFI |
10% Owner |
2014-12-22 |
3,569,210 |
2013-12-11 |
0 |
Premium* |
|
|
Groupon, Inc. |
GRPN |
10% Owner |
|
0 |
2013-09-13 |
41,260 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2013-06-03 |
2,483 |
Premium* |
|
|
Millennial Media Inc |
MM |
10% Owner |
2012-04-03 |
0 |
2012-10-29 |
8,196,614 |
Premium* |
|
|
Supernus Pharmaceuticals Inc |
SUPN |
10% Owner |
2012-05-04 |
10,641,250 |
2015-11-11 |
212,650 |
Premium* |
|
|
Audience Inc |
ADNC |
10% Owner |
2012-05-15 |
4,278,005 |
2013-11-05 |
0 |
Premium* |
|
|
Tesaro, Inc. |
TSRO |
10% Owner |
2012-07-03 |
0 |
2019-01-22 |
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
10% Owner |
|
0 |
2015-05-07 |
0 |
Premium* |
|
|
Workday, Inc. |
WDAY |
Director |
2013-11-22 |
4,402 |
2014-02-28 |
5,088 |
Premium* |
|
|
Tableau Software Inc |
DATA |
Director |
2013-05-22 |
0 |
2014-12-05 |
55,705 |
Premium* |
|
|
Interleukin Genetics Inc |
ILIU |
10% Owner |
|
0 |
2016-07-29 |
55,418,811 |
Premium* |
|
|
Epizyme, Inc. |
EPZM |
10% Owner |
2013-06-05 |
0 |
2016-01-12 |
6,261,502 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2023-01-26 |
2,237,196 |
Premium* |
|
|
Care.com Inc |
CRCM |
10% Owner |
2014-01-29 |
0 |
2017-11-06 |
504 |
Premium* |
|
|
Trevena Inc |
TRVN |
10% Owner |
2014-12-10 |
4,811,691 |
2014-02-05 |
0 |
Premium* |
|
|
Opower, Inc. |
OPWR |
10% Owner |
2016-06-14 |
0 |
2014-04-09 |
0 |
Premium* |
|
|
Ardelyx Inc |
ARDX |
10% Owner |
2014-12-23 |
0 |
2021-12-15 |
2,258,944 |
Premium* |
|
|
Roka Bioscience, Inc. |
ROKA |
10% Owner |
|
0 |
2014-07-22 |
3,216,810 |
Premium* |
|
|
Loxo Oncology, Inc. |
LOXO |
10% Owner |
2014-08-06 |
0 |
2014-08-06 |
1,789,420 |
Premium* |
|
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
2014-09-29 |
2,611,564 |
2015-07-01 |
556 |
Premium* |
|
|
Box Inc |
BOX |
10% Owner |
|
0 |
2015-01-28 |
0 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
10% Owner |
2017-02-13 |
952,809 |
|
0 |
Premium* |
|
|
Tracon Pharmaceuticals, Inc. |
TCON |
10% Owner |
2015-02-04 |
0 |
2016-11-29 |
2,758,039 |
Premium* |
|
|
Champions Biotechnology Inc |
CSBR |
10% Owner |
2020-03-06 |
1,713,720 |
2015-03-11 |
18,750,000 |
Premium* |
|
|
Nuvelo Inc |
ABIO |
10% Owner |
|
0 |
2018-02-26 |
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
10% Owner |
2023-10-03 |
2,922,773 |
2018-01-26 |
4,228,940 |
Premium* |
|
|
Avalo Therapeutics, Inc |
AVTX |
10% Owner |
2015-10-20 |
0 |
2015-10-20 |
594,245 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2020-01-24 |
102,478,668 |
Premium* |
|
|
Trivascular Technologies, Inc. |
TRIV |
10% Owner |
2016-02-03 |
0 |
2016-02-03 |
0 |
Premium* |
|
|
Kineta Ord Shs |
KA |
10% Owner |
2017-12-18 |
5,554,610 |
2016-02-17 |
0 |
Premium* |
|
|
Senseonics Holdings Inc |
SENS |
10% Owner |
2020-04-29 |
19,476,414 |
|
0 |
Premium* |
|
|
Aveo Pharmaceuticals Inc |
AVEO |
10% Owner |
|
0 |
2022-10-19 |
386 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
|
0 |
2016-12-19 |
5,215,128 |
Premium* |
|
|
Ra Pharmaceuticals, Inc. |
RARX |
10% Owner |
2020-04-02 |
0 |
2016-10-31 |
3,490,073 |
Premium* |
|
|
Cascadian Therapeutics, Inc |
CASC |
10% Owner |
|
0 |
2018-03-09 |
0 |
Premium* |
|
|
Mulesoft, Inc |
MULE |
10% Owner |
|
0 |
2018-05-01 |
0 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
2019-08-28 |
11,959,520 |
2020-09-14 |
829 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2020-12-04 |
6,451,056 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
2018-04-23 |
0 |
2018-04-23 |
3,312,877 |
Premium* |
|
|
Rhythm Pharmaceuticals, Inc. |
RYTM |
10% Owner |
2017-10-10 |
0 |
2017-10-10 |
4,909,956 |
Premium* |
|
|
Appian Corp |
APPN |
10% Owner |
2018-02-13 |
679 |
2018-02-13 |
13,895 |
Premium* |
|
|
Bloom Energy Corp |
BE |
Director |
2022-03-31 |
55,751 |
2021-11-12 |
0 |
Premium* |
|
|
Liquidia Technologies Inc |
LQDA |
10% Owner |
2018-07-30 |
0 |
2018-07-30 |
2,484,870 |
Premium* |
|
|
Elastic N.v. |
ESTC |
10% Owner |
2018-10-10 |
0 |
2018-10-10 |
2,197,503 |
Premium* |
|
|
Genocea Biosciences, Inc. |
GNCA |
10% Owner |
2019-02-14 |
0 |
2022-05-25 |
0 |
Premium* |
|
|
Trevi Therapeutics, Inc. |
TRVI |
10% Owner |
2019-05-09 |
0 |
2022-04-11 |
948,948 |
Premium* |
|
|
Mirum Pharmaceuticals, Inc. |
MIRM |
10% Owner |
2019-07-22 |
0 |
2023-06-13 |
11,348 |
Premium* |
|
|
Cloudflare, Inc. |
NET |
Director |
2023-11-20 |
6,325 |
2023-11-20 |
37,000 |
Premium* |
|
|
Oyster Point Pharma, Inc. |
OYST |
10% Owner |
2019-11-04 |
5,925,287 |
|
0 |
Premium* |
|
|
Galera Therapeutics, Inc. |
GRTX |
10% Owner |
2019-11-12 |
4,358,047 |
2019-11-12 |
0 |
Premium* |
|
|
Sprout Social, Inc. |
SPT |
10% Owner |
2020-08-17 |
5,582,854 |
2020-11-13 |
20,578 |
Premium* |
|
|
Casper Sleep Inc. |
CSPR |
10% Owner |
2020-02-10 |
6,222,412 |
|
0 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2020-03-16 |
4,013,995 |
2020-03-16 |
0 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
Nkarta, Inc. |
NKTX |
10% Owner |
2020-07-14 |
0 |
2020-07-14 |
2,902,115 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
2,437,689 |
Premium* |
|
|
Metacrine, Inc. |
MTCR |
10% Owner |
2020-09-18 |
0 |
2021-12-22 |
2,563,257 |
Premium* |
|
|
Eargo, Inc. |
EAR |
10% Owner |
2020-10-20 |
0 |
2021-05-24 |
1,231 |
Premium* |
|
|
Desktop Metal Ord Shs Class A |
DM |
10% Owner |
|
0 |
2021-06-08 |
878 |
Premium* |
|
|
Savara Inc |
SVRA |
10% Owner |
|
0 |
2023-07-17 |
24,471,264 |
Premium* |
|
|
Marker Therapeutics Inc |
MRKR |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
10,714,285 |
Premium* |
|
|
Coursera, Inc. |
COUR |
Director |
2023-11-02 |
31,536 |
2023-11-02 |
12,867,769 |
Premium* |
|
|
Bright Health Group Inc. |
BHG |
10% Owner |
|
0 |
2021-06-28 |
23,983,073 |
Premium* |
|
|
Monte Rosa Therapeutics, Inc. |
GLUE |
10% Owner |
2021-06-28 |
0 |
2021-06-28 |
7,692,298 |
Premium* |
|
|
Cvrx, Inc. |
CVRX |
10% Owner |
2021-07-02 |
0 |
2021-07-02 |
173,388 |
Premium* |
|
|
Robinhood Markets, Inc. |
HOOD |
Director |
2021-08-02 |
0 |
2022-05-12 |
23,850,644 |
Premium* |
|
|
Minerva Surgical Inc |
UTRS |
10% Owner |
2023-02-09 |
34,437,052 |
2021-10-26 |
0 |
Premium* |
|
|
BuzzFeed, Inc |
BZFD |
10% Owner |
2021-12-03 |
15,333,892 |
|
0 |
Premium* |
|
|
Ionq Ord Shs |
IONQ |
10% Owner |
2022-11-16 |
0 |
2022-11-16 |
1,141 |
Premium* |
|
|
Arcellx, Inc. |
ACLX |
10% Owner |
2022-12-20 |
0 |
2022-12-23 |
4,746,494 |
Premium* |
|
|
Revolution Acceleration Acquisit... |
BGRY |
10% Owner |
2023-07-20 |
0 |
2023-07-20 |
0 |
Premium* |
|
|
Korro Bio |
KRRO |
|
|
0 |
2024-04-22 |
1,090,793 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
10% Owner |
2024-01-29 |
0 |
2024-01-29 |
6,997 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
557 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 23
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRRO |
Korro Bio |
|
– – • |
2024-04-22 |
4 |
B |
$56.00 |
$999,992 |
I/I |
17,857 |
1,090,793 |
0.01 |
- |
|
| WTKND |
Welltek Incorporated |
10% Owner |
– – • |
2003-11-05 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,941,268 |
|
- |
|
| WTKND |
Welltek Incorporated |
10% Owner |
– – • |
2003-11-05 |
4 |
B |
$14.00 |
$5,600,000 |
I/I |
400,000 |
4,341,268 |
1.5 |
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
I/I |
3,269 |
3,269 |
|
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2003-12-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(70,027) |
0 |
|
- |
|
| ARDM |
Aradigm Corp |
10% Owner |
– – • |
2003-12-17 |
5 |
S |
$1.78 |
$5,819 |
I/I |
(3,269) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2006-04-12 |
4 |
B |
$9.00 |
$3,150,000 |
I/I |
350,000 |
350,000 |
1.5 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
2,913,512 |
3,263,512 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,746,869 |
3,746,859 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
B |
$6.50 |
$7,499,999 |
I/I |
1,153,846 |
4,900,715 |
1.5 |
- |
|
| VG |
Vonage Holdings Corp |
10% Owner |
– – • |
2006-05-30 |
4 |
A |
$0.00 |
$0 |
I/I |
27,930,422 |
6,838,051 |
|
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2006-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,127,067 |
|
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2007-02-06 |
4 |
OE |
$0.08 |
$75 |
I/I |
1,000 |
2,000 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2007-10-10 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,000,000) |
7,127,067 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2007-10-10 |
4 |
A |
$0.00 |
$0 |
I/I |
9,999 |
9,999 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2007-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
2,942 |
2,213 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2007-11-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(9,999) |
0 |
0 |
- |
|
| INWK |
Innerworkings Inc |
10% Owner |
– – • |
2007-11-12 |
4 |
S |
$13.75 |
$10,027 |
I/I |
(729) |
0 |
0 |
- |
|
| GYRE |
Gyre Therapeutics |
10% Owner |
– – • |
2008-01-17 |
4 |
A |
$7.07 |
$9,191,000 |
I/I |
1,300,000 |
4,563,512 |
0 |
- |
|
| ARYX |
Aryx Therapeutics Inc |
10% Owner |
– – • |
2008-11-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,469,274 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2009-01-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,103,283 |
1,103,283 |
0 |
- |
|
| ECHO |
Echo Global Logistics Inc |
10% Owner |
– – • |
2009-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,420,219 |
|
- |
|
| MOTR |
Motricity Inc |
10% Owner |
– – • |
2010-06-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
658,527 |
|
- |
|
| MOTR |
Motricity Inc |
10% Owner |
– – • |
2010-06-23 |
4 |
A |
$0.00 |
$0 |
D/D |
2,463,933 |
3,122,460 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2010-06-30 |
4 |
B |
$0.28 |
$6,551,724 |
D/D |
23,824,451 |
23,824,451 |
2.45 |
- |
|
557 Records found
|
|
Page 1 of 23 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
